Nodal promotes aggressive phenotype via Snail-mediated epithelial-mesenchymal transition in murine melanoma

Cancer Letters

Volumn 333, Issue 1, 2013, Pages 66-75

  Fang, Rui ^a   Zhang, Ge ^a   Guo, Qiang ^a   Ning, Fen ^a   Wang, Hao ^a   Cai, Shaohui ^b   Du, Jun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

EMT; Invasion; Melanoma; Nodal; Snail

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; PROTEIN KINASE B; PROTEIN NODAL; TRANSCRIPTION FACTOR SNAIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL MOTILITY; CELL STRUCTURE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENE SILENCING; MELANOMA B16; MELANOMA CELL; MOUSE; NODAL GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR SNAIL GENE; TUMOR GENE; TUMOR PROMOTION; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GLYCOGEN SYNTHASE KINASE 3; MATRIX METALLOPROTEINASE 2; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NODAL PROTEIN; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-AKT; TRANSCRIPTION FACTORS;

GASTROPODA; MURINAE;

EID: 84876072941     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.01.014     Document Type: Article

References (35)

1. Brennan J., Norris D.P., Robertson E.J. Nodal activity in the node governs left-right asymmetry. Genes Dev. 2002, 16:2339-2344.
2. Smith J.R., Vallier L., Lupo G., Alexander M., Harris W.A., Pedersen R.A. Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Dev. Biol. 2008, 313:107-117.
3. Topczewska J.M., Postovit L.M., Margaryan N.V., Sam A., Hess A.R., Wheaton W.W., Nickoloff B.J., Topczewski J., Hendrix M.J. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat. Med. 2006, 12:925-932.
4. Strizzi L., Postovit L.M., Margaryan N.V., Seftor E.A., Abbott D.E., Seftor R.E., Salomon D.S., Hendrix M.J. Emerging roles of Nodal and Cripto-1: from embryogenesis to breast cancer progression. Breast Dis. 2008, 29:91-103.
5. Papageorgiou I., Nicholls P.K., Wang F., Lackmann M., Makanji Y., Salamonsen L.A., Robertson D.M., Harrison C.A. Expression of nodal signalling components in cycling human endometrium and in endometrial cancer. Reprod. Biol. Endocrinol. 2009, 7:122.
6. Lawrence M.G., Margaryan N.V., Loessner D., Collins A., Kerr K.M., Turner M., Seftor E.A., Stephens C.R., Lai J., Postovit L.M., Clements J.A., Hendrix M.J. Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells. Prostate 2011, 71:1198-1209.
7. Zavadil J., Bottinger E.P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005, 24:5764-5774.
8. Shen M.M. Nodal signaling: developmental roles and regulation. Development 2007, 134:1023-1034.
9. Hendrix M.J., Seftor E.A., Seftor R.E., Kasemeier-Kulesa J., Kulesa P.M., Postovit L.M. Reprogramming metastatic tumour cells with embryonic microenvironments. Nat. Rev. Cancer 2007, 7:246-255.
10. Postovit L.M., Margaryan N.V., Seftor E.A., Kirschmann D.A., Lipavsky A., Wheaton W.W., Abbott D.E., Seftor R.E., Hendrix M.J. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc. Natl. Acad. Sci. USA 2008, 105:4329-4334.
11. Postovit L.M., Margaryan N.V., Seftor E.A., Hendrix M.J. Role of nodal signaling and the microenvironment underlying melanoma plasticity. Pigm. Cell Melanoma Res. 2008, 21:348-357.
12. Zeisberg M., Neilson E.G. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 2009, 119:1429-1437.
13. Arnold S.J., Hofmann U.K., Bikoff E.K., Robertson E.J. Pivotal roles for eomesodermin during axis formation, epithelium-to-mesenchyme transition and endoderm specification in the mouse. Development 2008, 135:501-511.
14. Guo Z., Cai S., Fang R., Chen H., Du J., Tan Y., Ma W., Hu H., Liu Y. The synergistic effects of CXCR4 and EGFR on promoting EGF-mediated metastasis in ovarian cancer cells. Colloids Surf. B Biointerfaces 2007, 60:1-6.
15. Jiang G.M., He Y.W., Fang R., Zhang G., Zeng J., Yi Y.M., Zhang S., Bu X.Z., Cai S.H., Du J. Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels. Int. J. Biochem. Cell Biol. 2010, 42:1840-1846.
16. Inman G.J., Nicolas F.J., Callahan J.F., Harling J.D., Gaster L.M., Reith A.D., Laping N.J., Hill C.S. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 2002, 62:65-74.
17. Guarino M. Epithelial-mesenchymal transition and tumour invasion. Int. J. Biochem. Cell Biol. 2007, 39:2153-2160.
18. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
19. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
20. Alves C.C., Carneiro F., Hoefler H., Becker K.F. Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. Front. Biosci. 2009, 14:3035-3050.
21. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F., Nieto M.A. The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2000, 2:76-83.
22. Vandewalle C., Van Roy F., Berx G. The role of the ZEB family of transcription factors in development and disease. Cell. Mol. Life Sci. 2009, 66:773-787.
23. Vandewalle C., Comijn J., De Craene B., Vermassen P., Bruyneel E., Andersen H., Tulchinsky E., Van Roy F., Berx G. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucl. Acids Res. 2005, 33:6566-6578.
24. Larue L., Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene 2005, 24:7443-7454.
25. Zhou B.P., Deng J., Xia W., Xu J., Li Y.M., Gunduz M., Hung M.C. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 2004, 6:931-940.
26. Kargiotis O., Chetty C., Gondi C.S., Tsung A.J., Dinh D.H., Gujrati M., Lakka S.S., Kyritsis A.P., Rao J.S. Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma. Oncogene 2008, 27:4830-4840.
27. Logullo A.F., Nonogaki S., Pasini F.S., Osorio C.A., Soares F.A., Brentani M.M. Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression. Oncol. Rep. 2010, 23:313-320.
28. Sarrio D., Rodriguez-Pinilla S.M., Hardisson D., Cano A., Moreno-Bueno G., Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 2008, 68:989-997.
29. Xue C., Plieth D., Venkov C., Xu C., Neilson E.G. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res. 2003, 63:3386-3394.
30. Haass N.K., Smalley K.S., Li L., Herlyn M. Adhesion, migration and communication in melanocytes and melanoma. Pigm. Cell Res. 2005, 18:150-159.
31. Miller A.J., Mihm M.C. Melanoma. New Engl. J. Med. 2006, 355:51-65.
32. Alonso S.R., Tracey L., Ortiz P., Perez-Gomez B., Palacios J., Pollan M., Linares J., Serrano S., Saez-Castillo A.I., Sanchez L., Pajares R., Sanchez-Aguilera A., Artiga M.J., Piris M.A., Rodriguez-Peralto J.L. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res. 2007, 67:3450-3460.
33. Christiansen J.J., Rajasekaran A.K. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 2006, 66:8319-8326.
34. Lahat G., Zhu Q.S., Huang K.L., Wang S., Bolshakov S., Liu J., Torres K., Langley R.R., Lazar A.J., Hung M.C., Lev D. Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies. PLoS ONE 2010, 5:e10105.
35. Govindarajan B., Sligh J.E., Vincent B.J., Li M., Canter J.A., Nickoloff B.J., Rodenburg R.J., Smeitink J.A., Oberley L., Zhang Y., Slingerland J., Arnold R.S., Lambeth J.D., Cohen C., Hilenski L., Griendling K., Martinez-Diez M., Cuezva J.M., Arbiser J.L. Overexpression of Akt converts radial growth melanoma to vertical growth melanoma. J. Clin. Invest. 2007, 117:719-729.